Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-22 02:21 | 2025-11-20 | ARQT | Arcutis Biotherapeutics Inc. | Gilbert Halley E | Director | Pharmaceutical Preparations | OPT+S | $27.55 | 16,532 | $455,442 | 22,123 | -42.8% |
| 2024-06-05 23:59 | 2024-06-03 | PCVX | Vaxcyte, Inc. | Gilbert Halley E | Director | Biological Products, (No Diagnostic Substances) | OPT+S | $73.00 | 18,200 | $1,328,600 | 5,625 | -76.4% |
| 2020-02-26 00:33 | 2020-02-21 | IRWD | IRONWOOD PHARMACEUTICALS INC | Gilbert Halley E | Officer; Chief Admin Officer & SVP | Pharmaceutical Preparations | SALE | $11.63 | 15,328 | $178,265 | 265,991 | -5.4% |
| 2020-02-05 00:02 | 2020-01-31 | IRWD | IRONWOOD PHARMACEUTICALS INC | Gilbert Halley E | Officer; Chief Admin Officer & SVP | Pharmaceutical Preparations | OPT+S | $12.05 | 60,000 | $723,000 | 281,319 | -17.6% |
| 2019-07-30 23:48 | 2019-07-26 | IRWD | IRONWOOD PHARMACEUTICALS INC | Gilbert Halley E | Officer; Chief Admin Officer & SVP | Pharmaceutical Preparations | OPT+S | $10.00 | 20,000 | $200,000 | 240,169 | -7.7% |
| 2019-05-14 23:12 | 2019-05-10 | IRWD | IRONWOOD PHARMACEUTICALS INC | Gilbert Halley E | Officer; Chief Admin Officer & SVP | Pharmaceutical Preparations | SALE | $10.53 | 4,055 | $42,699 | 238,240 | -1.7% |
| 2019-02-23 00:51 | 2019-02-20 | IRWD | IRONWOOD PHARMACEUTICALS INC | Gilbert Halley E | Officer; Chief Legal Officer | Pharmaceutical Preparations | SALE | $14.31 | 10,242 | $146,564 | 225,130 | -4.4% |
| 2018-07-05 23:12 | 2018-07-03 | IRWD | IRONWOOD PHARMACEUTICALS INC | Gilbert Halley E | Officer; Chief Legal Officer | Pharmaceutical Preparations | OPT+S | $19.75 | 29,551 | $583,632 | 0 | -100.0% |
| 2018-02-23 02:04 | 2018-02-21 | IRWD | IRONWOOD PHARMACEUTICALS INC | Gilbert Halley E | Officer; Chief Legal Officer | Pharmaceutical Preparations | SALE | $14.66 | 7,741 | $113,483 | 94,204 | -7.6% |
| 2017-06-26 23:22 | 2017-06-22 | IRWD | IRONWOOD PHARMACEUTICALS INC | Gilbert Halley E | Officer; Chief Legal Officer | Pharmaceutical Preparations | OPT+S | $19.75 | 35,000 | $691,250 | 0 | -100.0% |
| 2017-02-25 00:35 | 2017-02-22 | IRWD | IRONWOOD PHARMACEUTICALS INC | Gilbert Halley E | Officer; Chief Legal Officer | Pharmaceutical Preparations | SALE | $16.94 | 5,039 | $85,361 | 60,807 | -7.7% |
| 2017-02-16 02:12 | 2017-02-14 | IRWD | IRONWOOD PHARMACEUTICALS INC | Gilbert Halley E | Officer; Chief Legal Officer | Pharmaceutical Preparations | OPT+S | $16.75 | 37,385 | $626,199 | 0 | -100.0% |
| 2016-11-16 01:11 | 2016-11-11 | IRWD | IRONWOOD PHARMACEUTICALS INC | Gilbert Halley E | Officer; Chief Legal Officer | Pharmaceutical Preparations | OPT+S | $16.75 | 14,000 | $234,500 | 0 | -100.0% |
| 2016-05-27 23:47 | 2016-05-25 | IRWD | IRONWOOD PHARMACEUTICALS INC | Gilbert Halley E | Officer; Chief Legal Officer | Pharmaceutical Preparations | OPT+S | $12.19 | 20,275 | $247,152 | 64,537 | -23.9% |
| 2016-02-27 01:28 | 2016-02-24 | IRWD | IRONWOOD PHARMACEUTICALS INC | Gilbert Halley E | Officer; Chief Legal Officer | Pharmaceutical Preparations | SALE | $8.50 | 2,778 | $23,613 | 36,447 | -7.1% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.